KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pfizer (PFE) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Pfizer (PFE) over the last 17 years, with Q3 2025 value amounting to 0.45.

  • Pfizer's Equity Ratio rose 562.28% to 0.45 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.45, marking a year-over-year increase of 562.28%. This contributed to the annual value of 0.41 for FY2024, which is 543.26% up from last year.
  • Pfizer's Equity Ratio amounted to 0.45 in Q3 2025, which was up 562.28% from 0.43 recorded in Q2 2025.
  • In the past 5 years, Pfizer's Equity Ratio ranged from a high of 0.78 in Q4 2021 and a low of 0.39 during Q4 2023
  • For the 5-year period, Pfizer's Equity Ratio averaged around 0.46, with its median value being 0.44 (2025).
  • Per our database at Business Quant, Pfizer's Equity Ratio crashed by 4152.23% in 2022 and then soared by 1493.97% in 2023.
  • Over the past 5 years, Pfizer's Equity Ratio (Quarter) stood at 0.43 in 2021, then grew by 13.95% to 0.49 in 2022, then decreased by 19.13% to 0.39 in 2023, then grew by 5.43% to 0.41 in 2024, then grew by 7.41% to 0.45 in 2025.
  • Its last three reported values are 0.45 in Q3 2025, 0.43 for Q2 2025, and 0.44 during Q1 2025.